FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:453-455 February 7, 2002 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In their interesting study of the prognostic value of brain (B-type) natriuretic peptide in patients with acute coronary syndromes, de Lemos et al. (Oct. 4 issue)¹ did not thoroughly assess the possible confounding effect of a well-established prognostic marker, C-reactive protein. The authors state that 2525 patients provided plasma samples for the measurement of B-type natriuretic peptide and that C-reactive protein was also measured in 925 of these patients. The authors report that the univariate analysis showed only a moderately strong association between the level of B-type natriuretic peptide and the level of C-reactive protein (r=0.2, P<0.001). . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Huang, C-H, Tsai, M-S, Hsieh, C-C, Wang, T-D, Chang, W-T, Chen, W-J (2006). Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure. Heart 92: 1790-1794 [Abstract] [Full Text]